Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Good-first: a Multicohort Study of B/F/TAF As First-line ART in a Public Hospital in Eastern China

NCT06619288 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Good-first: a Multicohort Study of B/F/TAF As First-line ART in a Public Hospital in Eastern China
Lead sponsor
Affiliated Hospital of Nantong University
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2024
Completion date
June 30, 2026
Enrollment
630 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection